Search Results

240 results for CMED

The MindMed Psychedelic Revolution Will Take Years to Come to Fruition

By Alex Sirois, InvestorPlace Contributor

MNMD stock aspires to be a lot to many but could flop. Prices are low, risk is high and speculators could become savants.

Watch This Level to Determine a Santa Rally

By Jeff Remsburg, Editor, Investing Insider

5 Media Stocks to Buy Now

By Portfolio Grader

This week, five Media stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B”…

Trump Vs. Powell: What Investors Need to Know

By Louis Navellier, Editor, Growth Investor

In today’s Market 360, I want to touch on the latest developments that happened between Trump and Powell this week. I’ll cover what’s behind the…

Rate Hike Looms Large: 3 Financial Fund Picks

By

Minutes from the Fed???s last meeting made it clear that the central bank is set to hike interest rates in September. Compare Brokers….

InMed Pharmaceuticals (INM) Stock Soars 32% on R&D Updates

By William White, InvestorPlace Writer

InMed Pharmaceuticals (INM) stock is rocketing higher on Friday after the company revealed research and development (R&D) updates.

4 Financial Services Stocks to Sell Now

By Portfolio Grader

The ratings of four Financial Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

CME stock results show that CME Gr beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

CME stock results show that CME Gr beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

3 Inflation-Proof Stocks to Buy Now

By Marie Brodbeck, InvestorPlace Contributor

CME, Royal Dutch Shell (RDS.A) and Home Depot (HD) are all stocks to buy as inflation rises because they benefit from an increase in prices.

Strong Cash Balance Should Provide a Foundation for MindMed Stock

By Louis Navellier and the InvestorPlace Research Staff

Now that it has joined the Nasdaq Exchange, MNMD stock will have its ups and downs but firm financials should instill shareholder confidence.

Why Is Trxade Health (MEDS) Stock Down 13% Today?

By William White, InvestorPlace Writer

Trxade Health (MEDS) stock is falling on Tuesday after the company announced it would undergo a merger with Superlatus.

7 Leading MedTech Stocks for Next-Gen Health Solutions

By Josh Enomoto, InvestorPlace Contributor

With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.

Even with Higher Margin Requirements, Gold Still Glitters

By Jim Woods, Editor-in-Chief, Successful Investing, Intelligence Report, Bullseye Stock Trader

Even though new margin requirements increased the cost of gold futures by 22%, the metal is still a good buy for traders.

TENX Stock: 8 Things to Know About Tenax Therapeutics and PH Precision Med as Shares Rocket

By William White, InvestorPlace Writer

Tenax Therapeutics (TENX) stock is flying high on Tuesday after announcing it has acquired biotech company PH Precision Med.

MMEDF Stock Alert: Why Psychedelics Leader MindMed Is Climbing Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com

MMEDF stock is on the move today after psychedelics firm MindMed announced a new clinical trial. Here’s what you should know.

RMED Stock: 8 Things to Know About RA Medical as Retail Investors Look for the Next AMC

By William White, InvestorPlace Writer

RA Medical (RMED) stock is rocketing higher on Monday as retail traders on Reddit seek out their next target to send soaring.

Medifast Stock Is Still Worth Pouring Into

By Louis Navellier, Editor, Growth Investor

Prepared healthy meals are a trend that continue to boost Medifast’s growth. Here’s what investors need to know about MED stock after the recent dip…

3 Medical Devices Stocks to Buy Now

By Portfolio Grader

The grades of three medical devices stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong…

MindMed Stock Is Overvalued and Too Risky to Own

By Stavros Georgiadis, CFA, InvestorPlace Contributor

MindMed can be the future of psychedelic medicines, but without cash flow from revenue, MNMD stock is nothing to get excited about.

MindMed (MNMD) Stock Falls After Reverse Stock Split

By Dana Blankenhorn, InvestorPlace Contributor

MindMed’s price should be less volatile after its 1-for-15 reverse stock split, making it less interesting to speculators

3 Fresh Dip-Buying Opportunities (NFLX AMD CME)

By Tyler Craig, Tales of a Technician

Stocks survived Friday’s poor employment numbers with flying colors. These stock dips (NFLX, CME, AMD) are demanding the bulls’ attention.

MMEDF Stock: Why Psychedelics Play Mind Medicine Is Soaring Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com

MMEDF stock is climbing Friday thanks to news psychedelics company MindMed just raised another $27 million. Here’s what you should know.

The 3 Best Trades Right Now? The Whole Stock Market!

By Tyler Craig, Tales of a Technician

These three exchange stocks provide some of the best trades right now. Plus, you’ll be buying the whole stock market in one fell swoop!

4 – 10 of 240 results